Listed by the USPTO as TCHERKASSKAYA, OLGA V
Tech Center 1600 • Art Units: 1615
This examiner grants 56% of resolved cases
TCHERKASSKAYA, OLGA V is assigned to Tech Center 1600 and art unit 1615. The profile covers 852 resolved cases, with a 55.5% allowance rate and a median of 982 days to allowance. The interview lift is 46.4%, showing a strong positive association between interviews and outcomes relative to the profile's baseline allowance result.
The listed companies are Nicoventures Trading Limited, Syngenta AG, and Laboratorios Silanes S A De C V. The listed firms are BakerHostetler, Hudak, Shunk & Farine Co. LPA, and UltimatEdge IP Law Group, P.C. The large docket and moderate allowance rate support early substantive engagement, with interviews meriting particular attention when claim issues remain open.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17836661 | ORAL PRODUCT AND METHOD OF MANUFACTURE | Final Rejection | NICOVENTURES TRADING LIMITED |
| 16707580 | ORAL PRODUCT AND METHOD OF MANUFACTURE | Non-Final OA | NICOVENTURES TRADING LIMITED |
| 18683624 | PATCH AND PRODUCTION METHOD THEREOF | Final Rejection | KANEKA CORPORATION |
| 18870200 | HERBICIDAL DERIVATIVES | Non-Final OA | SYNGENTA CROP PROTECTION AG |
| 18849295 | COMPOSITIONS AND METHODS FOR CONTROLLING INSECTS | Non-Final OA | SYNGENTA CROP PROTECTION AG |
| 18549652 | LIQUID VISCOELASTIC SWALLOWING AID TO PROMOTE SAFE SWALLOWING OF SOLID ORAL DOSAGE FORMS (SODF) | Non-Final OA | SOCIETE DES PRODUITS NESTLE S.A. |
| 18456763 | CHEWABLE DISSOLVABLE NICOTINE TABLET | Final Rejection | Altria Client Services LLC |
| 18199614 | DRUG COMPOSITIONS AND METHODS OF PREPARING THE SAME | Non-Final OA | Applied Materials, Inc. |
| 18853162 | BIODEGRADABLE LIPIDOIDS AND COMPOSITIONS AND METHODS OF USE THEREOF FOR LIVER TARGETED DELIVERY | Non-Final OA | The Trustees of the University of Pennsylvania |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy55.5% of resolved applications examined by Olga V Tcherkasskaya were allowed (852 resolved cases), compared with 43.4% across Art Unit 1615 over the last five years.
This examiner's interview lift is +46.4 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Olga V Tcherkasskaya took 982 days on average from filing to allowance.
Olga V Tcherkasskaya examines applications in Art Unit 1615 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
